Weiss Multi Strategy Advisers LLC Adaptimmune Therapeutics PLC Transaction History

Weiss Multi Strategy Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$1.43 - $3.81 $57,200 - $152,400	-40,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$3.23 - $5.41 $80,750 - $135,250	-25,000 Reduced 38.46%	40,000 $161,000
Q4 2018 Feb 14, 2019	SELL	$3.76 - $14.16 $18,800 - $70,800	-5,000 Reduced 7.14%	65,000 $374,000
Q3 2018 Nov 14, 2018	SELL	$8.27 - $13.56 $82,700 - $135,600	-10,000 Reduced 12.5%	70,000 $949,000
Q1 2018 May 15, 2018	SELL	$7.1 - $11.56 $142,000 - $231,200	-20,000 Reduced 20.0%	80,000 $898,000
Q4 2017 Feb 14, 2018	SELL	$6.68 - $8.74 $6,680 - $8,740	-1,000 Reduced 0.99%	100,000 $668,000
Q3 2017 Nov 14, 2017	BUY	$4.93 - $8.93 $497,930 - $901,930	101,000	101,000 $827,000

150M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $105M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.